Hormonal therapy: Global castrate resistant prostate cancer market statistics, 2016-2027 (USD Million)
Global hormonal therapy castrate-resistant prostate cancer market size was valued at 5,216.3 USD million in 2017 and is estimated to grow at a compound annual growth rate (CAGR) of 7.4% from 2018 to 2027.